BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6355364)

  • 1. Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines.
    Wang CY; Al-Katib A; Lane CL; Koziner B; Fu SM
    J Exp Med; 1983 Nov; 158(5):1757-62. PubMed ID: 6355364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression.
    Al-Katib A; Koziner B
    Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of differentiation of African Burkitt's lymphoma cells by phorbol ester: possible relation with early B cells.
    Ho YS; Subhendu C; Hsu SM
    Cancer Invest; 1987; 5(2):101-7. PubMed ID: 2955857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
    Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
    Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
    Faille A; Turmel P; Charron DJ
    Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
    LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
    J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.
    Chen YX; Evans RL; Pollack MS; Lanier LL; Phillips JH; Rousso C; Warner NL; Brodsky FM
    Hum Immunol; 1984 Aug; 10(4):221-35. PubMed ID: 6332101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
    Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
    J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
    Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
    Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.
    Müller C; Ziegler A; Muller C; Hadam M; Waller HD; Wernet P; Müller G
    Immunobiology; 1985 Apr; 169(3):228-49. PubMed ID: 3873401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced expression of a monocytoid B lymphocyte antigen phenotype on the REH cell line.
    Patel B; Mohammad RM; Blaustein J; al-Katib A
    Am J Hematol; 1990 Mar; 33(3):153-9. PubMed ID: 2105637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for chemical differences in HLA-DR molecules on autologous acute lymphoblastic leukemia and B-lymphoblastoid cell lines.
    Graf L; Pesando JM
    Blood; 1987 Jan; 69(1):7-11. PubMed ID: 3491643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
    Guy K; Docherty LJ; Dewar AE
    Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
    Guy K; Krajewski AS; Dewar AE
    Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a monoclonal antibody (A12) that defines a human acute lymphoblastic leukemia-associated differentiation antigen.
    Carrel S; Heumann D; Sekaly RP; Zaech P; Buchegger F; Girardet C
    Hybridoma; 1983; 2(2):149-60. PubMed ID: 6205973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.